Status:
COMPLETED
Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment
Lead Sponsor:
University of Pennsylvania
Conditions:
Insomnia Chronic
Eligibility:
All Genders
30-50 years
Phase:
NA
Brief Summary
The longstanding view has been that insomnia, and other forms of sleep disturbance, emerge as a consequence of dementia and are the result of progressive neuronal damage. However, there is growing evi...
Eligibility Criteria
Inclusion
- Age 30-50
- Men and women
- Meet DSM5 Diagnostic Criteria for insomnia disorder
Exclusion
- Diagnosis or evidence of sleep disorders other than insomnia as determined by the screening questionnaires and clinical history
- Women who have been pregnant or lactating within the past six months
- Non-fluency in spoken or written English
- Current or past month shiftwork defined as working during the evening or night shift
- Current use of medications or OTC products that impact sleep
- Evidence of neurological abnormalities that could include the risks associated with lumbar puncture (e.g.papilledema, mass lesion, Chiari malformation).
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04073992
Start Date
September 1 2019
End Date
December 30 2022
Last Update
January 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104